HighTower Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.84M | Buy |
124,002
+1,275
| +1% | +$69.1K | 0.01% | 1045 |
|
|
2025
Q4 | $6.02M | Sell |
122,727
-166,175
| -58% | -$7.75M | 0.01% | 1074 |
|
|
2025
Q3 | $12.5M | Buy |
288,902
+7,132
| +3% | +$279K | 0.01% | 756 |
|
|
2025
Q2 | $10.8M | Sell |
281,770
-5,277
| -2% | -$202K | 0.01% | 766 |
|
|
2025
Q1 | $11.1M | Buy |
287,047
+3,585
| +1% | +$131K | 0.02% | 717 |
|
|
2024
Q4 | $9.59M | Sell |
283,462
-70,763
| -20% | -$2.55M | 0.01% | 770 |
|
|
2024
Q3 | $14.5M | Sell |
354,225
-8,974
| -2% | -$367K | 0.02% | 610 |
|
|
2024
Q2 | $14M | Sell |
363,199
-12,465
| -3% | -$524K | 0.02% | 587 |
|
|
2024
Q1 | $16.1M | Buy |
375,664
+935
| +0.2% | +$38.6K | 0.03% | 542 |
|
|
2023
Q4 | $13.9M | Sell |
374,729
-709
| -0.2% | -$25.5K | 0.02% | 584 |
|
|
2023
Q3 | $13.6M | Buy |
375,438
+25,662
| +7% | +$911K | 0.03% | 562 |
|
|
2023
Q2 | $12.5M | Buy |
349,776
+34,032
| +11% | +$1.22M | 0.02% | 572 |
|
|
2023
Q1 | $11.2M | Buy |
315,744
+4,989
| +2% | +$175K | 0.02% | 591 |
|
|
2022
Q4 | $10.9M | Buy |
310,755
+23,401
| +8% | +$779K | 0.03% | 579 |
|
|
2022
Q3 | $8.46M | Buy |
+287,354
| New | +$10.9M | 0.02% | 624 |
|
|
2022
Q2 | – | Sell |
-1,048,359
| Closed | -$57.1M | – | 3363 |
|
|
2022
Q1 | $57.1M | Buy |
1,048,359
+45,028
| +4% | +$2.45M | 0.13% | 165 |
|
|
2021
Q4 | $55.3M | Buy |
1,003,331
+74,326
| +8% | +$3.87M | 0.12% | 179 |
|
|
2021
Q3 | $44.4M | Buy |
929,005
+46,628
| +5% | +$2.34M | 0.12% | 178 |
|
|
2021
Q2 | $44M | Buy |
882,377
+151,773
| +21% | +$7.29M | 0.13% | 163 |
|
|
2021
Q1 | $32.6M | Buy |
730,604
+77,587
| +12% | +$3.52M | 0.1% | 199 |
|
|
2020
Q4 | $30M | Buy |
653,017
+24,463
| +4% | +$1.12M | 0.13% | 169 |
|
|
2020
Q3 | $29.6M | Buy |
628,554
+26,370
| +4% | +$1.32M | 0.14% | 151 |
|
|
2020
Q2 | $30.7M | Buy |
602,184
+63,075
| +12% | +$3.24M | 0.17% | 134 |
|
|
2020
Q1 | $25.6M | Buy |
539,109
+67,031
| +14% | +$3.58M | 0.17% | 133 |
|
|
2019
Q4 | $27.7M | Buy |
472,078
+13,286
| +3% | +$739K | 0.16% | 143 |
|
|
2019
Q3 | $24.5M | Sell |
458,792
-42,078
| -8% | -$2.16M | 0.13% | 160 |
|
|
2019
Q2 | $25M | Buy |
500,870
+26,159
| +6% | +$1.31M | 0.15% | 144 |
|
|
2019
Q1 | $24.8M | Buy |
474,711
+39,860
| +9% | +$1.99M | 0.17% | 132 |
|
|
2018
Q4 | $20.8M | Buy |
434,851
+19,257
| +5% | +$948K | 0.16% | 131 |
|
|
2018
Q3 | $20.9M | Sell |
415,594
-78,759
| -16% | -$4M | 0.15% | 147 |
|
|
2018
Q2 | $24.9M | Buy |
494,353
+66,548
| +16% | +$3.35M | 0.19% | 104 |
|
|
2018
Q1 | $20.9M | Buy |
427,805
+211,049
| +97% | +$9.83M | 0.18% | 125 |
|
|
2017
Q4 | $9.6M | Sell |
216,756
-152,629
| -41% | -$7.05M | 0.08% | 273 |
|
|
2017
Q3 | $18.8M | Sell |
369,385
-99,061
| -21% | -$5.03M | 0.16% | 138 |
|
|
2017
Q2 | $25.3M | Buy |
468,446
+58,512
| +14% | +$3.12M | 0.23% | 91 |
|
|
2017
Q1 | $21.6M | Buy |
409,934
+45,392
| +12% | +$2.3M | 0.21% | 100 |
|
|
2016
Q4 | $17.6M | Sell |
364,542
-15,062
| -4% | -$744K | 0.19% | 106 |
|
|
2016
Q3 | $20.5M | Buy |
379,604
+16,830
| +5% | +$923K | 0.24% | 90 |
|
|
2016
Q2 | $19.6M | Sell |
362,774
-58,802
| -14% | -$3.1M | 0.25% | 87 |
|
|
2016
Q1 | $21.4M | Buy |
421,576
+84,212
| +25% | +$4.19M | 0.07% | 101 |
|
|
2015
Q4 | $17M | Sell |
337,364
-71,131
| -17% | -$3.63M | 0.2% | 111 |
|
|
2015
Q3 | $19.6M | Buy |
408,495
+45,371
| +12% | +$2.36M | 0.26% | 85 |
|
|
2015
Q2 | $18.9M | Buy |
363,124
+135,716
| +60% | +$7.64M | 0.3% | 70 |
|
|
2015
Q1 | $13.1M | Buy |
227,408
+12,184
| +6% | +$698K | 0.2% | 113 |
|
|
2014
Q4 | $11.5M | Buy |
215,224
+1,650
| +0.8% | +$92.3K | 0.18% | 129 |
|
|
2014
Q3 | $12.3M | Buy |
213,574
+51,640
| +32% | +$3.17M | 0.21% | 111 |
|
|
2014
Q2 | $10.8M | Buy |
161,934
+13,919
| +9% | +$942K | 0.19% | 121 |
|
|
2014
Q1 | $9.89M | Buy |
148,015
+2,234
| +2% | +$151K | 0.19% | 117 |
|
|
2013
Q4 | $9.73M | Buy |
145,781
+20,406
| +16% | +$1.32M | 0.2% | 123 |
|
|
2013
Q3 | $7.86M | Sell |
125,375
-31,956
| -20% | -$2.06M | 0.2% | 125 |
|
|
2013
Q2 | $9.83M | Buy |
+157,331
| New | +$9.99M | 0.27% | 84 |
|
Other funds holding GSK
JEST
HighTower Advisors's GSK Position: Q1 2026 in Review
HighTower Advisors increased its GSK (GSK) stake by 1% in Q1 2026, buying an estimated $69.1K and bringing the position to 124,002 shares worth $6.84M. The position accounts for 0.01% of the portfolio, ranked #1045.
HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $57.1M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- HighTower Advisors held 124,002 shares of GSK worth $6.84M as of Q1 2026.
- HighTower Advisors bought 1,275 GSK shares in Q1 2026, an estimated $69.1K.
- GSK made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1045 holding.
- HighTower Advisors first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
- HighTower Advisors's GSK position peaked at $57.1M in Q1 2022.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.